17 PATIENT COUNSELING INFORMATION
17.1 Information for Patients and Caregivers
When appropriate, patients should be informed in advance that they may experience temporary loss of sensation and motor activity in the anesthetized part of the body following proper administration of lumbar epidural anesthesia. Also, when appropriate, the physician should discuss other information including adverse reactions in the ropivacaine package insert.
Inform patients that use of local anesthetics may cause methemoglobinemia, a serious condition that must be treated promptly. Advise patients or caregivers to seek immediate medical attention if they or someone in their care experience the following signs or symptoms: pale, gray, or blue colored skin (cyanosis); headache; rapid heart rate; shortness of breath; lightheadedness; or fatigue.
This product’s labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
For medical information about Ropivacaine hydrochloride injection please visit www.pfizermedinfo.com or call 1-800-438-1985.
Distributed by: Hospira, Inc., Lake Forest, IL 60045 USA